GlassScriptPhysician profile
Max Nathaniel Shapiro
NPI 1881056943
$6,094.64
in general payments reported to CMS, 2019-2025
12 companies · $514 in 2025
The $514 reported for 2025 was more than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $74.53 · 2023: $4,835 · 2024: $671 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $1,912 · Food and Beverage: $1,608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $1,912.01 |
| Food and Beverage | $1,608.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,624.44 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Smith+Nephew, INC. | $316.87 | 2023-2025 | Oasis, Collagenase Santyl, Acticoat 4" X 4" |
| Aroa Biosurgery Incorporated | $262.56 | 2024-2025 | |
| Polynovo North America LLC | $177.20 | 2024-2025 | Novosorb Btm |
| Avita Medical Americas, LLC | $162.23 | 2024 | |
| Integra Lifesciences Corporation | $136.01 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Boston Scientific Corporation | $119.12 | 2024 | Spyglass Discover |
| Tela Bio, INC. | $106.56 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Zimmer Biomet Holdings, INC. | $74.53 | 2022 | |
| Kerecis Limited | $69.20 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Depuy Synthes Sales INC. | $30.37 | 2025 | |
| Springworks Therapeutics, INC. | $15.55 | 2025 | Gomekli |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Max Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.